Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Who exactly will appoint third member of PDS?

is the elephant in the room with regards the 2012 Agreement.

The change from TPL to Alliacense is a distinction without a substantive difference .. other than the sanctioned siphoning going from 15% to 25%, from them being able to terminate the agreement or hold us hostage for "convenience", or for them to walk away with 9 years worth of Reverse engineering and Infringment Work Product that we paid for, or even our seeming inability to terminate the Agreement even for Cause; and on and on and on.

What is the motivation of a lawyer who would agree to these types of terms, especially when such a weak settlement results from an evidence heavy Fraud suit against their JV partner ?????????????

Share
New Message
Please login to post a reply